Accession Number: | 0001209191-21-004102 |
Date: | 2021-01-15 |
Issuer: | VAXCYTE, INC. (PCVX) |
Original Submission Date: |
WRIGHT-MITCHELL JANE
C/O VAXCYTE, INC.
353 HATCH DRIVE
FOSTER CITY, CA 94404
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-01-15 | M | 2,500 | a | $2.03 | 4,062 | direct | ||
COMMON STOCK | 2021-01-15 | S | 2,500 | d | $26.00 | 1,562 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.03 | 2021-01-15 | deemed execution date | M | 2,500 (d) | 2029-03-20 | common stock 2,500 | $2.03 | 204,968 | direct |
ID | footnote |
---|---|
f1 | includes 1,562 shares acquired under the employee stock purchase plan on november 17, 2020. |
f2 | the sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan. |
f3 | 1/4 of the shares subject to the option vested on january 7, 2020, and 1/48 of the shares vest monthly thereafter. |